Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
5.23
-0.18 (-3.33%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Armata Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $17.5. The average 1-year stock price forecast is 234.61% higher than the current stock price, while the lowest is $15 (+186.81%) and the highest is $20 (+282.41%).
Price Target: $17.5 (+234.61%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Armata Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $20 | Buy | Maintains | $20 | +282.41% | Aug 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +186.81% | Aug 13, 2026 |
Financial Forecast
Revenue This Year
4.25M
from 4.90M
Decreased by -13.34%
Revenue Next Year
5.50M
from 4.25M
Increased by 29.41%
EPS This Year
-0.82
from -1.31
EPS Next Year
-0.59
from -0.82
EPS and Forward PE are based on non-GAAP adjusted numbers.